Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Phase II, Multicentre, Randomised, Open-Label, Parallel Group Study to Evaluate the Safety and Efficacy of Velcade® added to Thalidomide-Dexamethasone Standard Treatment in Subjects with Multiple Myeloma who are Refractory to or Have Relapsed after Primary Therapy for Multiple Myeloma https://kusajili.com:443/Trial/f_Wkoc9lKUWWlbIMGoIPeQ%24a-phase-ii-multicentre-randomised-open-label-parallel-group-study-to-evaluate-the-safety-and-efficacy-of-velcader-added-to-thal
I have read and accept the terms of use of the site and the Privacy Policy
Send your message